Navigation Links
Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
Date:5/20/2008

Navigation system.

Speakers at the accredited symposium, "The Integrated EP Lab: The Future of Complex Arrhythmia Ablation," provided their perspectives on the complete array of Stereotaxis technologies, from the remote navigation of magnetic catheters to integrated information management and networking:

Dr. Andrea Natale, of the Texas Cardiac Arrhythmia Institute, endorsed magnetic navigation as an important tool for VT mapping of the endocardium and epicardium.

Prof. Karl-Heinz Kuck of St. Georg Hospital in Hamburg, presented data demonstrating the superior tissue contact that is achievable with magnetic catheters, optimizing safety and lesion formation at low contact forces. He noted that "it is almost impossible to perforate with a magnetic catheter."

While Prof. Carlo Pappone of San Raffaele University Hospital in Milan, Italy, using a Lasso(TM) catheter, confirmed 100% acute success in PV isolation with the magnetic irrigated catheter, the bulk of his remarks focused on the advanced simplification, accelerated learning curve, and improved communication that is now achievable with the Odyssey System and Network.

Dr. Gery Tomassoni of Central Baptist Hospital in Lexington, Kentucky underscored this point, suggesting that Odyssey will be the ultimate tool for the complete integration of existing and emerging technologies in the EP Lab.

"Stereotaxis is committed to improving EP lab efficiency at every point along the continuum of clinical practice, from enhancing the precision, efficacy and safety of remote navigation and consolidating information and systems management in the EP lab, to extending best practices across a growing network of interconnected users," said Bevil Hogg, CEO of Stereotaxis. Mr. Hogg continued, "We were delighted with the broad spectrum of clinical endorsements of our technology in the core curriculum, which represented the principal scientific content of the conference, and we were very encouraged
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
2. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
3. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
4. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
5. Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
6. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
7. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
8. Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report
9. Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market
10. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
11. Clinical Trial Best Practices: Savvy Marketers Plan Ahead with Early Communication Strategies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...OLIS, Nov. 20 Biotel Inc... its first quarter ended September 30, 2009 with n...e, on revenues of $3,263,000. This compares to ne..., on revenues of $3,168,000 for the first quarter ...r results, Biotel President and CEO Steve Springro...
(Date:11/20/2009)...IN LAKES, N.J., Nov. 20 ...today announced the completion of its acquisition ...mpany that develops and manufactures molecular dia...May 2009, BD and HandyLab announced an exclusive a...ular assays on the HandyLab Jaguar(TM) platform, t...
(Date:11/19/2009)..., Ireland, Nov. 19 Warner Chilcott...of its previously announced secondary offering of ...e public of $22.25 per share. The selling shareho...artners, DLJ Merchant Banking, J.P. Morgan Partner...ners, L.P., certain other institutional investors ...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Clinical Resourcing Firm ASG Changes Name to Ockham 61144 1NOVAVAX to Present at the Influenza Congress USA 2009 61142 1NOVAVAX to Present at the Influenza Congress USA 2009 61142 2Conference of International Experts Calls for a Focus on Well Being and The Person in Health 61140 1Conference of International Experts Calls for a Focus on Well Being and The Person in Health 61140 2Conference of International Experts Calls for a Focus on Well Being and The Person in Health 61140 3
...five studies presented at United European Gastroen...) -, - Non-invasive imaging system diagnoses his...tinal tract safely and effectively -, PARIS, Oct....he field of in vivo cellular imaging, announced th...five abstracts related to the company,s,Cellvizio(...
...use of cholesterol and hypertension medications la...0 to 44, Drop in the age of women using heart dise... N.J., Oct. 30 Heart disease,high blood pressure ...e,usually associated with the senior population - ...w research conducted by Medco Health Solutions,Inc...
Other Medicine Technology:New Clinical Studies Confirm Mauna Kea Technologies' Cellvizio(R) GI in Range of Procedures 2New Clinical Studies Confirm Mauna Kea Technologies' Cellvizio(R) GI in Range of Procedures 3New Clinical Studies Confirm Mauna Kea Technologies' Cellvizio(R) GI in Range of Procedures 4New Clinical Studies Confirm Mauna Kea Technologies' Cellvizio(R) GI in Range of Procedures 5Younger Adults Increasingly Treated for Heart Disease-related Conditions 2Younger Adults Increasingly Treated for Heart Disease-related Conditions 3Younger Adults Increasingly Treated for Heart Disease-related Conditions 4
(Date:11/21/2009)... New Haven Dental Group merges their practi...rd, CT. , (PRWEB) Novembe...d of partners Dr. David Gibson, Dr. Dean Cloutier,...ust merged their growing practice with that of est.... Pickman decided he wanted to retire from dentist...
(Date:11/20/2009)...TON, NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST ...al Meeting of Shareholders will be held on Monday,...to consider approval of two special resolutions. T...orize the sale of all or substantially all of the ...ided for in the asset purchase agreement dated Nov...
(Date:11/20/2009)... Mass., Nov. 20 Following a recall...ny removed from sale Shedd,s Country Crock ® ...,s Country Crock ® Side Dishes DELUXE Four Ch... ,, The following code dates and UPCs are affec...es DELUXE Cheddar Broccoli Rice 21 oz, UPC 0274002...
(Date:11/20/2009)..., Nov. 20 The American ... and Drug Administration (FDA) to establish approp...s. ,, Citing concern about the safety of white...the benefit of professional consultation or examin...application of chemically based tooth whitening or...
(Date:11/20/2009)...-SALEM, N.C., Nov. 20 S...on to redefine what it means to be "happy" during ... with a specialty in family counseling and chair o...ersity, Gladding says research shows that it is th... and even depression during the holidays. ,, Th...
Breaking Medicine News(10 mins):Health News:New Haven Dental Group Expands Their Vision 2Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2
...multi-disciplinary team of scientists from the Uni...he way for the development of a powerful new strat...prostate cancer. , The research is to use cuttin...rchers say that microscopic (5-100 nm) magnetic na...
...finds that enforcing existing laws cuts rate by 21...y News) -- American adolescents who live in states...ly to pick up a smoking habit than are those who l...ater, effect, the study also showed. , "Efforts to...
...ressional Members Address Negative Impacts of the ... Letter to the White House & Department of Hea...In a letter sent yesterday, a bipartisan group of ...lth and Human Services to review and rescind the c...
...GAAP Operating Loss Improves by 55% to $19.9 Milli...in/Lilly Alliance Restructures Exenatide Operation... April 16 Amylin Pharmaceuticals, Inc. (Nasdaq: ...ded March 31, 2009, which includes net product sal...
...ng registration critical to solving shortages, exp... News) -- Most Americans say they want to donate t...rs are registered to do so, a new survey shows. , ...,100 U.S. adults conducted in February by Astellas...
...BASAS, Calif., April 16 With so many people out o... for Social Security Disability Insurance (SSDI). ...ctory website to help people with disabilities to ...and take any job they can find. But, with fewer jo...
Other Medicine News:Health News:Pioneering medical nanotechnology offers new cancer breakthrough hope 2Health News:Tough Laws, Higher Prices Mean Fewer Kids Smoke 2Health News:Tough Laws, Higher Prices Mean Fewer Kids Smoke 3Health News:84 Members of Congress, Led by Rep. Betty Sutton, Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule Before April 18 Deadline 2Health News:84 Members of Congress, Led by Rep. Betty Sutton, Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule Before April 18 Deadline 3Health News:84 Members of Congress, Led by Rep. Betty Sutton, Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule Before April 18 Deadline 4Health News:84 Members of Congress, Led by Rep. Betty Sutton, Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule Before April 18 Deadline 5Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 2Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 3Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 4Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 5Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 6Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 7Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 8Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 9Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 10Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 11Health News:Survey Shows Many Want to Donate Organs, But Few Do 2Health News:Social Security Attorney Directory Helps to Speed SSDI Benefits 2
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: